Find this member on networks :

Dr. Charlotte Scholtes completed her doctoral studies in Biology, Genetics, and Cellular Biology at the University of Claude Bernard Lyon 1 (2014-2018).

Under the guidance of Dr. Ludivine Walter, her Ph.D. research centered on understanding the intricate relationship between mitochondrial dynamics actors and apoptosis during muscle degeneration, using the nematode model organism C. elegans. Notably, Charlotte Scholtes specialized in molecular biology, genetics, and microscopy during her doctoral studies. She was the recipient of a prestigious training grant from the Goupama pour la Santé foundation in France.

After obtaining her Ph.D., Charlotte Scholtes went to McGill University’s Goodman Cancer Institute in Montréal, Canada, where she did a postdoctoral fellowship under the supervision of Dr. Vincent Giguère (2018 – 2023). During this postdoc, her research interests shifted towards investigating the nuclear receptor ERRa, the master regulator of mitochondrial transcription and metabolism, in diverse metabolic contexts and tissues, expanding her expertise in biochemistry, omics techniques, and the use of murine models. She benefited from a Canderel foundation grant during this period.

In 2024, Charlotte Scholtes transitioned to the CarMeN Laboratory (Inserm U1060), to work alongside Dr. Jennifer Rieusset and delve into the complexities of type 2 diabetes. Her current project focuses on elucidating the early alterations of Mitochondria-Associated Membranes (MAMs) in the context of this metabolic disorder. She received a 3-year grant from the Fondation pour la Recherche Médicale (FRM) to help her return to France.